Journal Of Infection And Public Health SCI SCIE

国际简称：J INFECT PUBLIC HEAL 参考译名：感染与公共卫生杂志

主要研究方向：PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES 预警期刊审稿周期：49 Weeks

《感染与公共卫生杂志》(Journal Of Infection And Public Health)是一本由ELSEVIER SCIENCE LONDON出版的以PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -INFECTIOUS DISEASES为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开源期刊，近三年没有被列入预警名单。

3区中科院分区
Q1 JCR分区
323 年发文量
2.447 IF影响因子
开放是否OA
25 H-index
2008 创刊年份
4 issues/year 出版周期
English 出版语言

The Journal of Infection and Public Health, first official journal of the Saudi Arabian Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and the Saudi Association for Public Health, aims to be the foremost scientific, peer-reviewed journal encompassing infection prevention and control, microbiology, infectious diseases, public health and the application of healthcare epidemiology to the evaluation of health outcomes. The point of view of the journal is that infection and public health are closely intertwined and that advances in one area will have positive consequences on the other.

The journal will be useful to all health professionals who are partners in the management of patients with communicable diseases, keeping them up to date. The journal is proud to have an international and diverse editorial board that will assist and facilitate the publication of articles that reflect a global view on infection control and public health, as well as emphasizing our focus on supporting the needs of public health practitioners.

It is our aim to improve healthcare by reducing risk of infection and related adverse outcomes by critical review, selection, and dissemination of new and relevant information in the field of infection control, public health and infectious diseases in all healthcare settings and the community.

[ 查看全部 ]

投稿咨询加急咨询

投稿热线：400-888-7501

Journal Of Infection And Public Health期刊信息

ISSN：1876-0341
出版语言：English
是否OA：开放
E-ISSN：1876-035X
出版地区：ENGLAND
是否预警：否
出版商：ELSEVIER SCIENCE LONDON
出版周期：4 issues/year
创刊时间：2008
开源占比：0.9674
Gold OA文章占比：96.04%
OA被引用占比：1
出版国人文章占比：0.12
出版撤稿占比：0
研究类文章占比：78.97%

Journal Of Infection And Public Health CiteScore评价数据

CiteScore

SJR

SNIP

CiteScore 指数

11.10

1.183

1.501

学科类别	分区	排名	百分位
大类：Medicine 小类：Public Health, Environmental and Occupational Health	Q1	22 / 577	96%
大类：Medicine 小类：Infectious Diseases	Q1	32 / 304	89%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Journal Of Infection And Public Health中科院评价数据

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	3区	INFECTIOUS DISEASES 传染病学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生	3区 3区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	3区	INFECTIOUS DISEASES 传染病学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生	4区 3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	3区	INFECTIOUS DISEASES 传染病学 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生	3区 3区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	是	医学	3区	PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生 INFECTIOUS DISEASES 传染病学	3区 4区

Journal Of Infection And Public Health JCR评价数据

JCR 分区等级	按学科分区
Q1	INFECTIOUS DISEASES	Q1
Q1	PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH	Q1

Journal Of Infection And Public Health历年数据统计

影响因子

中科院分区

Journal Of Infection And Public Health中国学者发文选摘

1、Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: A cross-sectional surve
2、Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, Chin
3、Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategie
4、Brucella cultures characteristics, clinical characteristics, and infection biomarkers of human Brucellosi
5、Perceptions and worries about monkeypox, and attitudes towards monkeypox vaccination among medical workers in China: A cross-sectional surve
6、Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in Chin
7、Fatal multisystem inflammatory syndrome in a 78-year-old adult after severe COVID-19 pneumonia during 2022 Omicron variant epidemic in Shanghai, Chin
8、Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, Chin